Private Manufacturers' Thresholds to Invest in Comparative Effectiveness Trials
New Clinical Insights into Chronic Obstructive Pulmonary Disease and Their Implications for Pharmacoeconomic Analyses
Counting the Cost of Not Costing HIV Health Facilities Accurately
The Cost Effectiveness of Newer Epilepsy Treatments
The State of Health Economic Research in South Africa
Value-of-Information Analysis to Reduce Decision Uncertainty Associated with the Choice of Thromboprophylaxis after Total Hip Replacement in the Irish Healthcare Setting
Patient Preferences for Community Pharmacy Asthma Services
Validity of Cost and Utility Results?
The Authors' Reply
Is There a Role for Pharmacoeconomics in Decision Making?
The Authors' Reply